Literature DB >> 2166812

Incorporation of chimeric gag protein into retroviral particles.

R A Weldon1, C R Erdie, M G Oliver, J W Wills.   

Abstract

The product of the Rous sarcoma virus (RSV) gag gene, Pr76gag, is a polyprotein precursor which is cleaved by the viral protease to yield the major structural proteins of the virion during particle assembly in avian host cells. We have recently shown that myristylated forms of the RSV Gag protein can induce particle formation with very high efficiency when expressed in mammalian cells (J. W. Wills, R. C. Craven, and J. A. Achacoso, J. Virol. 63:4331-4343, 1989). We made use of this mammalian system to examine the abilities of foreign antigens to be incorporated into particles when fused directly to the myristylated Gag protein. Our initial experiments showed that removal of various portions of the viral protease located at the carboxy terminus of the RSV Gag protein did not disrupt particle formation. We therefore chose this region for coupling of iso-1-cytochrome c from Saccharomyces cerevisiae to Gag. This was accomplished by constructing an in-frame fusion of the CYC1 and gag coding sequences at a common restriction endonuclease site. Expression of the chimeric gene resulted in synthesis of the Gag-cytochrome fusion protein and its release into the cell culture medium. The chimeric particles were readily purified by simple centrifugation, and transmission electron microscopy of cells that produced them revealed a morphology similar to that of immature type C retrovirions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166812      PMCID: PMC247881          DOI: 10.1128/JVI.64.9.4169-4179.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  An avian oncovirus mutant deficient in genomic RNA: characterization of the packaged RNA as cellular messenger RNA.

Authors:  B Gallis; M Linial; R Eisenman
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

2.  Sequence of the gene for iso-1-cytochrome c in Saccharomyces cerevisiae.

Authors:  M Smith; D W Leung; S Gillam; C R Astell; D L Montgomery; B D Hall
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  Large-scale growth of Rous sarcoma virus.

Authors:  R E Smith
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

Review 4.  Retro-secretion of recombinant proteins.

Authors:  J W Wills
Journal:  Nature       Date:  1989-07-27       Impact factor: 49.962

5.  Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching.

Authors:  M V Nermut; H Frank; W Schäfer
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

6.  Preparations enriched for "immature" murine leukemia virus particles that remain in tissue culture fluids are deficient in Pr65gag proteolyic activity.

Authors:  Y Yoshinaka; K Ishigame; T Ohno; S Kageyama; K Shibata; R B Luftig
Journal:  Virology       Date:  1980-01-15       Impact factor: 3.616

Review 7.  The budding mechanisms of enveloped animal viruses.

Authors:  K Simons; H Garoff
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

8.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus.

Authors:  P R Shank; M Linial
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells.

Authors:  V M Vogt; D A Bruckenstein; A P Bell
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

View more
  78 in total

1.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.

Authors:  N K Krishna; J W Wills
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.

Authors:  Akash Patnaik; John W Wills
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.

Authors:  J B Bowzard; R J Visalli; C B Wilson; J S Loomis; E M Callahan; R J Courtney; J W Wills
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Transposition of a Ty3 GAG3-POL3 fusion mutant is limited by availability of capsid protein.

Authors:  J Kirchner; S B Sandmeyer; D B Forrest
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Protein delivery using engineered virus-like particles.

Authors:  Stanislaw J Kaczmarczyk; Kalavathy Sitaraman; Howard A Young; Stephen H Hughes; Deb K Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

8.  NC-mediated nucleolar localization of retroviral gag proteins.

Authors:  Timothy L Lochmann; Darrin V Bann; Eileen P Ryan; Andrea R Beyer; Annie Mao; Alan Cochrane; Leslie J Parent
Journal:  Virus Res       Date:  2012-10-02       Impact factor: 3.303

9.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.

Authors:  Y L Lu; R P Bennett; J W Wills; R Gorelick; L Ratner
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.